Angiotensin converting enzyme 2 - An ally or a Trojan horse? Implications to SARS-CoV-2 -related cardiovascular complications: Angiotensin-converting enzyme 2: An ally or a Trojan horse? Implications to SARS-CoV-2-related cardiovascular complications

Zaid Abassi, Suheir Assady, Emad E. Khoury, Samuel N. Heyman

Research output: Contribution to journalLetterpeer-review

41 Scopus citations
Original languageEnglish
Pages (from-to)H1080-H1083
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Issue number5
StatePublished - May 2020


  • Angiotensin-Converting Enzyme 2
  • Angiotensin-Converting Enzyme Inhibitors/administration & dosage
  • Betacoronavirus/metabolism
  • COVID-19
  • Cardiovascular Diseases/enzymology
  • Coronavirus Infections/complications
  • Humans
  • Myocardium/enzymology
  • Pandemics
  • Peptidyl-Dipeptidase A/biosynthesis
  • Pneumonia, Viral/complications
  • SARS-CoV-2

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)
  • Physiology

Cite this